Clik here to view.
Novocure to Participate in the BIO 2017 CEO & Investor Conference
Tuesday, February 7th 2017 at 12:00pm UTC ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ:NVCR) announced today that it will participate in the BIO 2017 CEO & Investor Conference on Feb. 13,...
View ArticleClik here to view.
Exelixis to Present at the Leerink Partners Global Healthcare Conference on...
Tuesday, February 7th 2017 at 9:05pm UTC — Presentation to be webcast on www.exelixis.com — SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M....
View ArticleClik here to view.
FDA Grants Cellectis IND Approval to Proceed with the Clinical Development of...
Monday, February 6th 2017 at 9:30pm UTC Cellectis’ UCART123 Product Candidate Targets AML and BPDCN NEW YORK–(BUSINESS WIRE)– class= »bwalignl »> Regulatory News: Cellectis (Paris:ALCLS)...
View ArticleClik here to view.
PAREXEL International to Present at Leerink Partners Healthcare Conference
Tuesday, February 7th 2017 at 6:00pm UTC BOSTON–(BUSINESS WIRE)– PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Leerink Partners Healthcare...
View ArticleClik here to view.
Pivotal Phase 3 Data Results for TRULANCE™ (plecanatide) in the Treatment of...
Tuesday, February 7th 2017 at 2:30pm UTC NEW YORK–(BUSINESS WIRE)– Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced that the American Journal of Gastroenterology has published detailed...
View ArticleClik here to view.
InVivo Therapeutics to Present at 2017 BIO CEO & Investor Conference
Tuesday, February 7th 2017 at 1:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (NVIV) today announced that Mark Perrin, Chief Executive Officer and Chairman, will...
View ArticleClik here to view.
Lewis County General is First Hospital in North Country to Deploy Xenex...
Wednesday, February 8th 2017 at 1:21am UTC LOWVILLE, N.Y.–(BUSINESS WIRE)– Lewis County General Hospital today announced it is the first hospital in the North Country to use the Xenex LightStrike™...
View ArticleClik here to view.
Synergy Pharmaceuticals to Present at Leerink Partners 6th Annual Global...
Wednesday, February 8th 2017 at 1:30pm UTC NEW YORK–(BUSINESS WIRE)– Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced that Marino Garcia, the company’s EVP and Chief Strategy Officer, will...
View ArticleClik here to view.
Ovid Therapeutics and NeuroPointDX Announce Collaboration to Identify...
Thursday, February 9th 2017 at 1:05pm UTC – Partnership Marks First Step in Ovid Therapeutics’ Commitment to Biomarker Development – NEW YORK & MADISON, Wis.–(BUSINESS WIRE)– Ovid Therapeutics, a...
View ArticleClik here to view.
Centrexion Therapeutics to Present at the 19th Annual BIO CEO & Investor...
Thursday, February 9th 2017 at 12:30pm UTC BOSTON–(BUSINESS WIRE)– Centrexion Therapeutics, a company focused on advancing the treatment of chronic pain with one of the largest exclusively...
View ArticleClik here to view.
ArQule to Present at The Leerink Partners 6th Annual Global Healthcare...
Wednesday, February 8th 2017 at 12:00pm UTC BURLINGTON, Mass.–(BUSINESS WIRE)– ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief...
View ArticleClik here to view.
CohBar, Inc.’s CEO Simon Allen to Present at the 2017 BIO CEO & Investor...
Thursday, February 9th 2017 at 1:30pm UTC MENLO PARK, Calif.–(BUSINESS WIRE)– CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), a preclinical stage biotechnology company focused on developing mitochondria...
View ArticleClik here to view.
Acorda Announces Positive Phase 3 Clinical Trial Results for CVT-301
Thursday, February 9th 2017 at 11:00am UTC SPAN-PD trial met primary endpoint: CVT-301 showed statistically significant improvement of motor function compared to placebo New Drug Application (NDA)...
View ArticleClik here to view.
Cue Biopharma to Present at 2017 BIO CEO & Investor Conference
Thursday, February 9th 2017 at 2:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Cue Biopharma, Inc. (Cue), an immunotherapy company developing biologics engineered to selectively modulate disease-relevant...
View ArticleClik here to view.
Ignyta to Present at the LEERINK Partners 6th Annual Global Healthcare...
Wednesday, February 8th 2017 at 12:00pm UTC SAN DIEGO–(BUSINESS WIRE)– Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob...
View ArticleClik here to view.
Puma Biotechnology to Present at LEERINK Partners Global Healthcare Conference
Wednesday, February 8th 2017 at 9:15pm UTC LOS ANGELES–(BUSINESS WIRE)– Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive...
View ArticleClik here to view.
HealthReveal Announces $10.8 Million Series A Funding
Thursday, February 9th 2017 at 2:00pm UTC Investment supports convergence of advanced analytics and the clinical Internet of things to preempt the consequences of chronic disease NEW YORK–(BUSINESS...
View ArticleClik here to view.
BioTime to Present at Two Upcoming Investor Conferences
Monday, February 13th 2017 at 12:00pm UTC ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing and commercializing products addressing...
View ArticleClik here to view.
venBio Comments on Immunomedics Partnership Announcement
Friday, February 10th 2017 at 9:14pm UTC Company is Blatantly Spurning Will of Stockholders by Announcing a Deal Four Business Days Before Annual Meeting Was Set to Take Place and Postponing the...
View ArticleClik here to view.
Manhattan Scientifics Announces Retirement of its Current $2.5M Long Term...
Monday, February 13th 2017 at 2:00pm UTC NEW YORK–(BUSINESS WIRE)– Manhattan Scientifics Inc. (OTCQB: MHTX) announced today that equity capital to retire $2.0M of the $2.5M debt was raised by...
View Article